抗MRSA药物诱导的异性肺炎的药监测研究:基于FDA不良事件报告系统的分析
Naoto Okada1, Takahiro Niimura2, Atsuyuki Saisyo1
1Pharmacy Department, Yamaguchi University Hospital, Yamaguchi, Japan.
Open forum infectious diseases
|August 21, 2023
概括
乙性肺炎 (EP) 是一种与抗甲基耐药黄金葡萄球菌 (anti-MRSA) 药物相关的罕见不良事件. 达普托米辛 (DAP) 是唯一的抗MRSA药物,显示了EP的不成比例信号,特别是在治疗时间较长的老年男性中.
科学领域:
- 药物监督 药物监督 药物监督
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
背景情况:
- 乙性肺炎 (EP) 是一种罕见的药物不良事件,其特征不明.
- 这项研究重点关注与抗甲基耐药黄金葡萄球菌 (anti-MRSA) 药物相关的不良事件.
研究的目的:
- 分析EP发生率与抗MRSA剂之间的不成比例.
- 使用FAERS数据库来描述由抗MRSA药物诱导的EP事件.
主要方法:
- 贝叶斯信任传播神经网络和报告赔率比率方法用于不成比例分析.
- 使用了2012年第四季度至2022年第四季度的食品和药物管理局不良事件报告系统 (FAERS) 数据库.
- 分析了抗MRSA药物诱导的EP的特征.
主要成果:
- 在抗MRSA药物中,仅用达普素 (DAP) 检测到EP的显著不成比例信号.
- 与daptomycin相关的EP病例与男性性别 (OR1.94),年龄大于70岁 (OR2.70) 和治疗时间长于21天 (OR5.08) 相关.
- 灵敏度分析证实了EP信号对DAP的强度.
结论:
- 达普托米辛被确定为唯一的抗MRSA药物,具有异性肺炎的不成比例信号.
- 男性性别,晚年和延长治疗时间是DAP诱导EP的潜在风险因素.
- 临床医生应在达普素治疗期间保持对EP的警.
更多相关视频
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
14.7K
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
13.0K
相关概念视频
01:19Pharmacovigilance
889
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
889
01:25Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
342
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
342